VIDEO: Immunotherapy ‘trying to move the needle forward’ in upper GI cancer care
Click Here to Manage Email Alerts
BOSTON – Christy S. Harris, PharmD, BCOP, FHOPA, discussed a presentation on the role of immunotherapy in upper gastrointestinal cancer and how it’s “trying to move the needle forward” in care.
The presentation was given at Hematology/Oncology Pharmacy Association Annual Meeting.
Harris, associate professor of pharmacy practice at Massachusetts College of Pharmacy and Health Sciences and a clinical pharmacy specialist at Dana-Farber Cancer Institute, also talked about a presentation on considerations when taking patients with chronic myeloid leukemia off of a tyrosine kinase inhibitor in this video interview with Healio.
“All of that was fascinating and really helpful for us in our everyday practice,” Harris said.
Collapse
DiPippo AJ, Savoy JM. Implementation of treatment-free remission in chronic myeloid leukemia. Presented at: HOPA Annual Conference; Mar. 30-Apr. 2, 2022; Boston.
Zadlo, JL. Reaching a conclusion in an area of confusion: Teasing out the details of immunotherapy in gastroesophageal cancers. Presented at: HOPA Annual Conference; Mar. 30-Apr. 2, 2022; Boston.
Click Here to Manage Email Alerts